Tsk, tsk Lowman, what kind of son risks his mama's old age money on investments with "explosive potential?"
I agree about the filings: we gotta' lower the level of expectations for LTC sales. When DR says "early next year" for sales, "IPO in Novermber" (2006) comes to mind.
I expect nothing positive until the end of the year. And I'm happy that DR won't be PR'ing wish lists instead of material facts.
This PPS blows, and while I wouldn't advise my mom to buy any shares (unless she stopped playing the lottery and used that money), the LTC story has progressed considerably. What we need now is to see the technology progressed to those areas that are well and truly beyond existing technologies: organ suturing would be the breakthrough that would set LTC apart. Unfortunately, proving that up in FDA approved clinical trials is so far beyond the financial ken of CTGI that we have no choice but to recruit a sugar daddy. Let's hope Frank and Richard still got the rolodex's working.
Market Data 
Markets 
